Pre-operatively, circulating neutrophil counts were found to correlate with increased tumor burden, as well as with increased levels of the neutrophil-mobilizing cytokines, interleukin (IL)-1β, IL-17A and tumor necrosis factor-α (TNF-α). Here, IL17A is linked to neoplasm.